SCHEDULE 13D//SEC Filing
NovaBay Pharmaceuticals, Inc. SCHEDULE 13D
Accession 0001829126-25-008155
CIK 0002028474other
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 8:28 PM ET
Size
168.2 KB
Accession
0001829126-25-008155
Issuer
Framework Ventures IV L.P.
CIK 0002028474
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0002028474
Filing Metadata
- Form type
- SCHEDULE 13D
- Filed
- Oct 14, 8:00 PM ET
- Accepted
- Oct 15, 8:28 PM ET
- Size
- 168.2 KB